Hey Derrickcan...I believe you have it mixed up with milestone payments. As far as I know the $120 million milestone payments in total would have come from Viopharma, if and when their drug were to receive approval from the fda for FA. I don't believe anyone knows the structure of the pfzier deal for Ponzeumab, and Pfzier is doing everything in their power not to pay or give any credit to Intellect for it. I still believe we are going to see a buyout here within the next few months for anywhere between .025 to .05. GLTA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.